Comparison
8p11 2 Deletion Syndrome C4304505 vs Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
Clinical comparison between 8p11 2 Deletion Syndrome and Abnormal Amplitude OF Light Adapted Flicker Electroretinogram for differential diagnosis and treatment planning.
8p11 2 Deletion Syndrome C4304505
A genetic condition caused by deletion of material from chromosome 8. It may lead to developmental delays, distinctive facial features, and other health concerns. Treatment focuses on addressing specific symptoms with multidisciplinary support.
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
An abnormal eye test response to flickering light, which tests cone cell function. This finding may indicate problems with color vision cells and typically requires specialist eye evaluation.
6 comparison axes
Onset
8p11 2 Deletion Syndrome C4304505
0-null
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
Variable
Onset patterns differ
Severity
8p11 2 Deletion Syndrome C4304505
moderate
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
moderate
Different severity levels
Chronic
8p11 2 Deletion Syndrome C4304505
Chronic
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
Chronic
Differing course
Communicable
8p11 2 Deletion Syndrome C4304505
No
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
No
Different transmission
Body System
8p11 2 Deletion Syndrome C4304505
congenital
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
ophthalmologic
Same/different system
Category
8p11 2 Deletion Syndrome C4304505
genetic
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
genetic
Different category
Bottom line
8p11-2-deletion-syndrome-C4304505 and abnormal-amplitude-of-light-adapted-flicker-electroretinogram-C4072969 have similar characteristics
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 8p11 2 Deletion Syndrome C4304505 | Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969 | Discriminating power |
|---|---|---|---|
| Developmental pattern | May include developmental delay and congenital features from birth or early childhood. | No developmental pattern is implied by the ERG finding alone. | High |
| Visual function | Eye involvement is not established as a defining feature from the supplied data. | Suggests possible cone-pathway dysfunction, including color-vision concerns, pending specialist review. | High |
| Physical features | May include distinctive facial features and other variable health concerns. | No characteristic physical features are defined by this test abnormality. | Moderate |
When to favor each condition
Choose 8p11 2 Deletion Syndrome C4304505 when
Confirmed chromosomal deletion
Use when genetic testing identifies deletion of material from chromosome 8p11.2.
High
Multisystem congenital presentation
Consider when developmental delay and congenital features prompt genetics evaluation.
Moderate
Need for coordinated support
Choose when management requires symptom-specific multidisciplinary care rather than an isolated eye finding.
Moderate
Choose Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969 when
Abnormal cone-function ERG
Use when light-adapted flicker testing shows an abnormal amplitude.
High
Isolated ophthalmic concern
Appropriate when the available evidence is limited to retinal electrophysiology.
High
Unexplained color-vision concern
May support specialist eye evaluation, but does not establish a specific disease.
Moderate
How key tests differ
| Test | 8p11 2 Deletion Syndrome C4304505 | Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969 | Interpretation |
|---|---|---|---|
| Chromosomal genetic testing | May identify a deletion involving 8p11.2. | Not expected to explain the ERG result by itself. | Genetic confirmation defines the syndrome; it is not indicated solely by this comparison. |
| Light-adapted flicker ERG | No specific result is established for the syndrome. | Abnormal amplitude is the defining finding. | Interpret with full ERG protocol, clinical history, and ophthalmologist review. |
| Comprehensive eye examination | Used to assess any individual ocular concerns. | Needed to correlate the abnormal result with vision and retinal findings. | Neither concept should be diagnosed from examination alone. |
Prognosis comparison
8p11 2 Deletion Syndrome C4304505
- Outcome
- Variable and symptom-dependent; a uniform outcome is not established.
- Factors
- Deletion extent, associated anomalies, developmental needs, and available support may influence course.
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
- Outcome
- Outcome depends on the underlying cause, which this result alone does not establish.
- Factors
- Related retinal findings, visual function, progression, and specialist diagnosis are important.
Time frame: Both may be long-term, but individual course varies.
Clinician interpretation and confirmatory evaluation are essential.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Delays and learning or developmental support needs may occur. Not established from the ERG abnormality alone. Needs vary and require individualized assessment. |
| Visual impairment | A specific visual complication is not established here. Possible cone-related visual dysfunction may be present. Severity and permanence cannot be inferred from the supplied description. |
| Associated health concerns | Other congenital or medical concerns may occur. An underlying retinal or systemic cause may need investigation. The finding does not identify the cause. |
Patient education highlights
- HighDifferent meanings
One is a genetic condition; the other is an abnormal eye-test result requiring interpretation.
- HighSpecialist follow-up
Genetics and relevant specialists guide the syndrome; ophthalmology interprets the ERG.
- MediumAvoid assumptions
An abnormal amplitude does not by itself prove a named retinal disease or prognosis.